Viking Therapeutics (VKTX) Misses Q1 EPS by 8c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Abu Dhabi's G42 Weighs US Ownership To Safeguard AI Chip Access - Bloomberg
• UBS Reiterates Buy Rating on PVH Corp (PVH) on Strong Earnings Growth Potential
• CIENA (CIEN) PT Lowered to $394 at UBS on Group Multiple Compression